MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract
Right arrow Full Text
Right arrow Submit a response
Services
Right arrow Alert me to new issues of the journal
No Nitric Oxide for HO-1 from Sodium Nitroprusside
Mol Pharmacol Schröder 69: 1507

Erratum

Correction to “No Nitric Oxide for HO-1 from Sodium Nitroprusside”

In the above Perspective (Schröder H (2006) Mol Pharmacol 69:1507-1509), a reference is missing from the reference list that is cited in the text on page 1508. The missing reference is as follows:

Wang J, Fillebeen C, Chen G, Andriopoulos B, and Pantopoulos K (2006) Sodium nitroprusside promotes IRP2 degradation via an increase in intracellular iron and in the absence of S nitrosylation at C178. Mol Cell Biol 26:1948-1954.

The online version of this article will be corrected in departure from print.

The printers regret this error and apologize for any confusion or inconvenience it may have caused.





This Article
Right arrow Abstract
Right arrow Full Text
Right arrow Submit a response
Services
Right arrow Alert me to new issues of the journal


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics